MiNK Therapeutics INKT Ratios (2020-2026)

NASDAQ INKT
$11.84 +0.22 (+1.89%)
As of: Aug 21, 2026 · 11:39 AM EDT
Ratios Sep2020 Dec2020 Mar2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets Average (Quarter)
22.16M38.19M33.63M28.19M23.37M19.03M14.35M9.79M6.01M5.72M8.61M8.85M6.55M4.99M3.38M8.72M14.60M12.31M10.00M
Invested Capital (Quarter)
5.03M5.95M7.04M7.59M8.36M
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-1.66-7.90-1.28-2.36-1.71-953.49-1.45-1.42-2.27111.25383.00-1.46-1.25-32.8693.13-2.93-0.5123.29720.45-0.74
Debt Ratio (Quarter)
1.230.150.190.240.330.420.590.610.430.630.86
Times Interest Earned (Quarter)
-1.66-7.90-1.28-2.36-1.71-953.49-1.45-1.42-2.27111.25383.00-1.46-1.25-32.8693.13-2.93-0.5123.29720.45-0.74
Valuation
Enterprise Value (Quarter)
-0.82M-38.89M-34.69M-29.80M-24.16M-19.64M-14.90M-10.60M-6.40M-3.37M-5.82M-9.30M-6.33M-4.58M-3.20M-1.68M-9.50M-13.36M-9.53M-8.81M
Return Ratios
Return on Capital Employed (Quarter)
-498.01%-169.05%-214.85%-302.01%-289.69%-378.26%-972.92%4,167.75%424.81%388.05%1,145.51%-985.13%2,740.50%142.56%113.82%264.12%-805.32%-255.42%-493.87%
Return on Assets (Quarter)
-0.02%-0.01%-0.02%-0.02%-0.02%-0.02%-0.03%-0.04%-0.06%-0.05%-0.03%-0.02%-0.02%-0.03%-0.04%-0.02%-0.01%-0.02%-0.03%